Radiopharm Theranostics Limited (RADX) Net margin 2023–2025
Radiopharm Theranostics Limited (RADX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1055.3%FY2025 · since FY2023: -11838.6% → -1055.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1055.3% | +14969.0 pp |
| FY2024 | -16024.3% | -4185.7 pp |
| FY2023 | -11838.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RADX financial trends
RADX RevenueRADX Net incomeRADX Gross profitRADX Gross marginRADX Operating incomeRADX Operating marginRADX Operating cash flowRADX Free cash flowRADX Capital expendituresRADX Return on equityRADX Stock buybacksRADX Dividends paidRADX Total assetsRADX Total liabilitiesRADX Shareholders’ equityRADX overview →